Skip to content

CG Oncology CGON Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$40.77M+0.5%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$33.57M
Summit Therapeutics logo
Summit TherapeuticsSMMT
$20.89M+189%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$47.86M-5.8%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$77.62M-6.3%

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's operating lease liabilities (total)?
CG Oncology (CGON) reported operating lease liabilities (total) of $4.58M in Q1 2026.
How has CG Oncology's operating lease liabilities (total) changed year-over-year?
CG Oncology's operating lease liabilities (total) increased by 341.6% year-over-year, from $1.04M to $4.58M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.